http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0656881-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-522
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J73-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-20
filingDate 1993-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71a4f4919457cab375b4d0441bac46b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0b12708c84900650d4d31eedfed589f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_635bd4a089c99d2958d531f65b13eb56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37459e99b5a2002cfbae7c9da568e5fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_040d7c62762c1b90b27e44be92fec037
publicationDate 1994-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0656881-A
titleOfInvention Novel 7β-substituted-4-aza-5α-cholestane-ones as 5α-reductase inhibitors
abstract (57) [Summary] (Corrected) [Constitution] The following formula [Wherein R is selected from hydrogen, methyl or ethyl and the dotted lines a and b are 5α hydrogen when b is present, H a represents a double bond provided that a does not exist; Z represents oxo, ═CH—R ′, etc., and R ′ represents H or alkyl. 7β-substituted-4-aza-5α-cholestane-represented by 3-one and related compounds. [Effect] It is effective against benign prostatic hyperplasia, acne, hirsutism, androgenetic alopecia, androgenetic alopecia, and prostatitis by inhibiting the compound steroid 5α-reductase.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3312746-A1
priorityDate 1992-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4377584-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57005
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID184699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53680048
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57005
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID191550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233859016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID185670
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59327

Total number of triples: 42.